Pharmaceutical

Opinion: STAT readers on teaching medical students abou...

“One of the reasons I retired was because I was expected to perform these annual...

Opinion: The WHO recognizes noma after years of medical...

What took so long for the World Health Organization to recognize the devastating...

STAT+: Illumina says it will divest Grail, starting a c...

Illumina, the leading maker of DNA sequencing machines, said it would divest Gra...

STAT+: The biggest health care deals of 2023

Vertical integration, hospital mergers, and important small deals defined the he...

Sanofi and AstraZeneca to supply additional RSV doses t...

The US government is set to receive an additional 230,000 doses of RSV injection...

Reneo cuts 70% of staff following Phase III trial failure

Reneo’s mavodelpar failed to meet its endpoints in the Phase III trial in primar...

Teva and Biolojic enter therapeutic antibody developmen...

Teva Pharmaceutical has signed a licence agreement with Biolojic Design for the ...

FDA approves US WorldMeds’s iwilfin for neuroblastoma

The US FDA granted approval for US WorldMeds’ iwilfin for use as an oral mainten...

Biden shakes up US drug pricing landscape with inflatio...

The Inflation Reduction Act targets annual savings of $25m by 2031 by requiring ...

MSD’s Welireg secures FDA approval for renal cell carci...

This is the second FDA approval for MSD’s HIF-2α inhibitor following a 2021 appr...

Biovac receives IFC loan for vaccine manufacturing in A...

Biovac has received an investment and advisory package from the IFC to support v...

NIH panel calls for fewer, better-paid postdocs in bid ...

The NIH panel called for raising minimum postdoc salaries to $70,000 — an increa...

Opinion: The Biden administration’s plan to use march-i...

The Biden administration’s plan to use march-in rights to address drug prices wo...

Morning Rounds: Americans’ health is trending downward,...

Understand how science, health policy, and medicine shape the world everyday. Si...

FDA chastens pet companies over antibiotics

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Bluebird claims big insurer will c...

Bluebird Bio claimed a large insurer has agreed to cover its newly approved sick...